Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 11, 2022

View Archived Issues

IFI27L2A and IFITM3 increase their expression after stroke

US Department of Health & Human Services patents compounds for SARS-CoV-2 infection

eNAMP-neutralizing MAb reduces ARDS severity in rat and porcine models

CK-BB predicts never awakening in patients treated with hypothermia after cardiac arrest

Virpax reports preclinical findings on Envelta for acute and chronic pain

Researchers unveil therapeutic targets in ischemic stroke

Targeting TRPM2 using tat-M2NX improves functional outcome following MCAO

No pain, health gain with biochemical mimicry of caloric restriction?

Alkem signs license agreement with Harvard for technology to treat vascular disease

Regulating ANXA1 activity is an approach for treating sickle cell disease-associated stroke

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...